Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum

International Immunopharmacology

Volumn 9, Issue 11, 2009, Pages 1272-1280

  Dudhgaonkar, Shailesh ^a   Thyagarajan, Anita ^a   Sliva, Daniel ^a,b,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Ganoderma lucidum; Inflammation; Macrophages; Signal transduction; Triterpenes

Indexed keywords

CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLOOXYGENASE 2; GANODERMA LUCIDUM EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN AP 1; PROTEIN P37; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TRITERPENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG SYNTHESIS; ENDOTOXEMIA; ENZYME ACTIVITY; FEMALE; GANODERMA LUCIDUM; IC 50; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; FEMALE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; REISHI; TRITERPENES;

EID: 70249137176     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.07.011     Document Type: Article

References (72)

1. Lawrence T., Willoughby D.A., and Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2 (2002) 787-795
2. Kaplanski G., Marin V., Montero-Julian F., Mantovani A., and Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation.[see comment]. Trends Immunol 24 (2003) 25-29
3. Bosca L., Zeini M., Traves P.G., and Hortelano S. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 208 (2005) 249-258
4. Hagemann T., Robinson S.C., Schulz M., Trumper L., Balkwill F.R., and Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25 (2004) 1543-1549
5. Lin C.Y., Lin C.J., Chen K.H., Wu J.C., Huang S.H., and Wang S.M. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett 580 (2006) 3042-3050
6. Kimura Y.N., Watari K., Fotovati A., Hosoi F., Yasumoto K., Izumi H., et al. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci 98 (2007) 2009-2018
7. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.[see comment]. Trends Immunol 23 (2002) 549-555
8. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4 (2004) 71-78
9. Chen J.J.W., Lin Y.C., Yao P.L., Yuan A., Chen H.Y., Shun C.T., et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 23 (2005) 953-964
10. Sliva D. Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini Rev Med Chem 4 (2004) 873-879
11. Yun T.K. Update from Asia. Asian studies on cancer chemoprevention. Ann N Y Acad Sci 889 (1999) 157-192
12. Yuen J.W.M., and Gohel M.D.I. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53 (2005) 11-17
13. Sliva D. Ganoderma lucidum in cancer research. Leuk Res 30 (2006) 767-768
14. Hua K.F., Hsu H.Y., Chao L.K., Chen S.T., Yang W.B., Hsu J., et al. Ganoderma lucidum polysaccharides enhance CD14 endocytosis of LPS and promote TLR4 signal transduction of cytokine expression. J Cell Physiol 212 (2007) 537-550
15. Ji Z., Tang Q., Zhang J., Yang Y., Jia W., and Pan Y. Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharmacol 112 (2007) 445-450
16. Jiang J., Slivova V., and Sliva D. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 29 (2006) 695-703
17. Thyagarajan A., Jiang J., Hopf A., Adamec J., and Sliva D. Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med 18 (2006) 657-664
18. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437-457
19. Weinstein S.L., Sanghera J.S., Lemke K., DeFranco A.L., and Pelech S.L. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J Biol Chem 267 (1992) 14955-14962
20. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
21. Hambleton J., Weinstein S.L., Lem L., and DeFranco A.L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci U S A 93 (1996) 2774-2778
22. Paul A., Cuenda A., Bryant C.E., Murray J., Chilvers E.R., Cohen P., et al. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell Signal 11 (1999) 491-497
23. Li C., Li Y., and Sun H.H. New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Nat Prod Res 20 (2006) 985-991
24. Li C., Yin j., Guo F., Zhang D., and Sun H.H. Ganoderic acid Sz, a new lanostanoid from the mushroom Ganoderma lucidum. Nat Prod Res 19 (2005) 461-465
25. Ma J., Ye Q., Hua Y., Zhang D., Cooper R., Chang M., et al. New lanostanoids from the mushroom Ganoderma lucidum. J Nat Prod 65 (2002) 72-75
26. Jiang J., Slivova V., Harvey K., Valachovicova T., and Sliva D. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49 (2004) 209-216
27. Sliva D., Rizzo M.T., and English D. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277 (2002) 3150-3157
28. Sliva D., Harvey K., Mason R., Lloyd Jr. F., and English D. Effect of phosphatidic acid on human breast cancer cells exposed to doxorubicin. Cancer Invest 19 (2001) 783-790
29. Kwak H.J., Song J.S., Heo J.Y., Yang S.D., Nam J.Y., and Cheon H.G. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation. J Pharmacol Exp Ther 315 (2005) 1188-1195
30. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
31. Matthews C.P., Colburn N.H., and Young M.R. AP-1 a target for cancer prevention. Curr Cancer Drug Targets 7 (2007) 317-324
32. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 2 (1997) 240-246
33. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
34. Matsushime H., Roussel M.F., Ashmun R.A., and Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65 (1991) 701-713
35. Sherr C.J. Cancer cell cycles. Science (1996) 1672-1677
36. Morgan D.O. Principles of CDK regulation. Nature 374 (1995) 131-134
37. Laskin D.L., and Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 35 (1995) 655-677
38. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 23 (2001) 99-109
39. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117 (2007) 1175-1183
40. Lapa e Silva J.R., Possebon da Silva M.D., Lefort J., and Vargaftig B.B. Endotoxins, asthma, and allergic immune responses. Toxicology 152 (2000) 31-35
41. Bogdan C. Nitric oxide and the immune response. [see comment]. Nature Immunol 2 (2001) 907-916
42. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol 23 (2002) 144-150
43. Behm B.W., and Bickston S.J. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2008) CD006893
44. Park E.K., Choo M.K., Han M.J., and Kim D.H. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 133 (2004) 113-120
45. Wu M.J., Wang L., Ding H.Y., Weng C.Y., and Yen J.H. Glossogyne tenuifolia acts to inhibit inflammatory mediator production in a macrophage cell line by downregulating LPS-induced NF-kappa B. J Biomed Sci 11 (2004) 186-199
46. Ko H.C., Kuo Y.H., Wei B.L., and Chiou W.F. Laxifolone A suppresses LPS/IFN-gamma-induced NO synthesis by attenuating NF-kappaB translocation: role of NF-kappaB p105 level. Planta Med 71 (2005) 514-519
47. Hwang Y.H., Lee J.W., Hahm E.R., Jung K.C., Lee J.H., Park C.H., et al. Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-kappaB and AP-1 and also reduced osteoclast activity and survival. Biochem Biophys Res Commun 337 (2005) 815-823
48. Lee J.H., Koo T.H., Yoon H., Jung H.S., Jin H.Z., Lee K., et al. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem Pharmacol 72 (2006) 1311-1321
49. Kim N.D., Kim E.M., Kang K.W., Cho M.K., Choi S.Y., and Kim S.G. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. Br J Pharmacol 140 (2003) 661-670
50. Jeong H.G., Pokharel Y.R., Han E.H., and Kang K.W. Induction of cyclooxygenase-2 by ginsenoside Rd via activation of CCAAT-enhancer binding proteins and cyclic AMP response binding protein. Biochem Biophys Res Commun 359 (2007) 51-56
51. Ikeda Y., Murakami A., and Ohigashi H. Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages. Biochem Pharmacol 70 (2005) 1497-1505
52. Yang H.L. Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human hepatoma cell line BEL7402. Biotechnol Lett 27 (2005) 835-838
53. Chang U.M., Li C.H., Lin L.I., Huang C.P., Kan L.S., and Lin S.B. Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 79 (2006) 1129-1139
54. Tang W., Liu J.W., Zhao W.M., Wei D.Z., and Zhong J.J. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80 (2006) 205-211
55. Yue Q.X., Xie F.B., Guan S.H., Ma C., Yang M., Jiang B.H., et al. Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes. Cancer Sci 99 (2008) 1461-1470
56. Lin S.B., Li C.H., Lee S.S., and Kan L.S. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72 (2003) 2381-2390
57. Yue Q.X., Cao Z.W., Guan S.H., Liu X.H., Tao L., Wu W.Y., et al. Proteomics characterization of the cytotoxic mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 7 (2008) 949-961
58. Hartwell L.H., and Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science 246 (1989) 629-634
59. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33 (2000) 261-274
60. Chen F., Castranova V., and Shi X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159 (2001) 387-397
61. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 4 (2002) E131-136
62. Trembley J.H., Chen Z., Rodrigues C.M., Kren B.T., and Steer C.J. Genomic organization and promoter characterization of the rat cyclin B1 gene. Gene 255 (2000) 93-104
63. Lin Z.B. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99 (2005) 144-153
64. Zhu X.L., Chen A.F., and Lin Z.B. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 111 (2007) 219-226
65. Lin K.I., Kao Y.Y., Kuo H.K., Yang W.B., Chou A., Lin H.H., et al. Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1. J Biol Chem 281 (2006) 24111-24123
66. Haak-Frendscho M., Kino K., Sone T., and Jardieu P. Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cell Immunol 150 (1993) 101-113
67. Hsu H.Y., Hua K.F., Wu W.C., Hsu J., Weng S.T., Lin T.L., et al. Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells. J Cell Physiol 215 (2008) 15-26
68. Wang G., Zhao J., Liu J., Huang Y., Zhong J.J., and Tang W. Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol 7 (2007) 864-870
69. Lakshmi B., Ajith T.A., Sheena N., Gunapalan N., and Janardhanan K.K. Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India. Teratog Carcinog Mutagen Suppl 1 (2003) 85-97
70. Akihisa T., Nakamura Y., Tagata M., Tokuda H., Yasukawa K., Uchiyama E., et al. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers 4 (2007) 224-231
71. Iwatsuki K., Akihisa T., Tokuda H., Ukiya M., Oshikubo M., Kimura Y., et al. Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. J Nat Prod 66 (2003) 1582-1585
72. Ko H.H., Hung C.F., Wang J.P., and Lin C.N. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry 69 (2008) 234-239